Clinical Trials: Lowereing A1C, Weight Change & CV Data

See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.

Incretins: How we got here, where we're at and what is coming next - DiabetesontheNet

Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials - Kidney International Supplements

PDF] Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.

Mean A1c reduction in clinical studies of SGLT2 inhibitors

JCM, Free Full-Text

What the studies say about targets for glycaemic control (including hypoglycaemia)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

A1C and Weight Results RYBELSUS® (semaglutide) tablets 7 mg or 14 mg

The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2020

PDF) Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes

Hemoglobin A1c Reduction and CV Risk Improvement: Correlation, Causation and Clinical Recommendations

Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP